CN103446269A - Pharmaceutical composition for preventing birth defects and improving memory - Google Patents
Pharmaceutical composition for preventing birth defects and improving memory Download PDFInfo
- Publication number
- CN103446269A CN103446269A CN2013104243830A CN201310424383A CN103446269A CN 103446269 A CN103446269 A CN 103446269A CN 2013104243830 A CN2013104243830 A CN 2013104243830A CN 201310424383 A CN201310424383 A CN 201310424383A CN 103446269 A CN103446269 A CN 103446269A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- effect
- pharmaceutical composition
- calcium
- function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000032170 Congenital Abnormalities Diseases 0.000 title claims abstract description 40
- 230000007698 birth defect Effects 0.000 title claims abstract description 37
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 18
- 206010010356 Congenital anomaly Diseases 0.000 title abstract description 5
- 239000002994 raw material Substances 0.000 claims description 19
- 230000000694 effects Effects 0.000 abstract description 85
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 33
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 32
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 28
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 27
- 239000011575 calcium Substances 0.000 abstract description 24
- 239000011777 magnesium Substances 0.000 abstract description 24
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 23
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract description 23
- 229910052791 calcium Inorganic materials 0.000 abstract description 23
- 235000001465 calcium Nutrition 0.000 abstract description 23
- 229910052749 magnesium Inorganic materials 0.000 abstract description 23
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 20
- 229930003316 Vitamin D Natural products 0.000 abstract description 19
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract description 19
- 235000019166 vitamin D Nutrition 0.000 abstract description 19
- 239000011710 vitamin D Substances 0.000 abstract description 19
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract description 19
- 229940046008 vitamin d Drugs 0.000 abstract description 19
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract description 18
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract description 18
- 239000010949 copper Substances 0.000 abstract description 17
- 239000011701 zinc Substances 0.000 abstract description 17
- 229910052725 zinc Inorganic materials 0.000 abstract description 17
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract description 16
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract description 16
- 229910052802 copper Inorganic materials 0.000 abstract description 16
- 239000011669 selenium Substances 0.000 abstract description 16
- 235000019155 vitamin A Nutrition 0.000 abstract description 16
- 239000011719 vitamin A Substances 0.000 abstract description 16
- 229940045997 vitamin a Drugs 0.000 abstract description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 15
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 abstract description 15
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract description 15
- 229930003268 Vitamin C Natural products 0.000 abstract description 15
- 229910052732 germanium Inorganic materials 0.000 abstract description 15
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 abstract description 15
- 229910052750 molybdenum Inorganic materials 0.000 abstract description 15
- 239000011733 molybdenum Substances 0.000 abstract description 15
- 239000011591 potassium Substances 0.000 abstract description 15
- 229910052700 potassium Inorganic materials 0.000 abstract description 15
- 235000007686 potassium Nutrition 0.000 abstract description 15
- 229910052711 selenium Inorganic materials 0.000 abstract description 15
- 235000019154 vitamin C Nutrition 0.000 abstract description 15
- 239000011718 vitamin C Substances 0.000 abstract description 15
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract description 14
- 229930003427 Vitamin E Natural products 0.000 abstract description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 14
- 229910052710 silicon Inorganic materials 0.000 abstract description 14
- 239000010703 silicon Substances 0.000 abstract description 14
- 229910052712 strontium Inorganic materials 0.000 abstract description 14
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 abstract description 14
- 235000019165 vitamin E Nutrition 0.000 abstract description 14
- 239000011709 vitamin E Substances 0.000 abstract description 14
- 229940046009 vitamin E Drugs 0.000 abstract description 14
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 13
- 229930003448 Vitamin K Natural products 0.000 abstract description 13
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract description 13
- 229940088594 vitamin Drugs 0.000 abstract description 13
- 229930003231 vitamin Natural products 0.000 abstract description 13
- 235000013343 vitamin Nutrition 0.000 abstract description 13
- 239000011782 vitamin Substances 0.000 abstract description 13
- 235000019168 vitamin K Nutrition 0.000 abstract description 13
- 239000011712 vitamin K Substances 0.000 abstract description 13
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract description 13
- 229940046010 vitamin k Drugs 0.000 abstract description 13
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract description 12
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 12
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract description 12
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract description 9
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract description 9
- 230000036541 health Effects 0.000 abstract description 8
- 229910052742 iron Inorganic materials 0.000 abstract description 6
- 235000013399 edible fruits Nutrition 0.000 abstract description 5
- 230000035935 pregnancy Effects 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 3
- 244000241838 Lycium barbarum Species 0.000 abstract description 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 2
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 2
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 229940052810 complex b Drugs 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 44
- 239000003814 drug Substances 0.000 description 42
- 230000006870 function Effects 0.000 description 36
- 239000011573 trace mineral Substances 0.000 description 34
- 235000013619 trace mineral Nutrition 0.000 description 34
- 210000004369 blood Anatomy 0.000 description 31
- 239000008280 blood Substances 0.000 description 31
- 239000000203 mixture Substances 0.000 description 30
- 229930003270 Vitamin B Natural products 0.000 description 28
- 235000019156 vitamin B Nutrition 0.000 description 28
- 239000011720 vitamin B Substances 0.000 description 28
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 24
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 22
- 229960005069 calcium Drugs 0.000 description 22
- 229960000304 folic acid Drugs 0.000 description 22
- 235000019152 folic acid Nutrition 0.000 description 22
- 239000011724 folic acid Substances 0.000 description 22
- 229940091250 magnesium supplement Drugs 0.000 description 22
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 21
- 210000000582 semen Anatomy 0.000 description 19
- 239000011651 chromium Substances 0.000 description 18
- 229910052804 chromium Inorganic materials 0.000 description 17
- 230000007812 deficiency Effects 0.000 description 17
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 15
- 229960003975 potassium Drugs 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 229940091258 selenium supplement Drugs 0.000 description 14
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 13
- 208000007502 anemia Diseases 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 229940055726 pantothenic acid Drugs 0.000 description 12
- 235000019161 pantothenic acid Nutrition 0.000 description 12
- 239000011713 pantothenic acid Substances 0.000 description 12
- -1 physical factor Substances 0.000 description 12
- 230000002265 prevention Effects 0.000 description 12
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 11
- 235000013734 beta-carotene Nutrition 0.000 description 11
- 239000011648 beta-carotene Substances 0.000 description 11
- 229960002747 betacarotene Drugs 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 230000004060 metabolic process Effects 0.000 description 11
- 150000003254 radicals Chemical class 0.000 description 11
- 239000000654 additive Substances 0.000 description 10
- 230000000996 additive effect Effects 0.000 description 10
- 230000001093 anti-cancer Effects 0.000 description 10
- 229960002685 biotin Drugs 0.000 description 10
- 235000020958 biotin Nutrition 0.000 description 10
- 239000011616 biotin Substances 0.000 description 10
- 210000003754 fetus Anatomy 0.000 description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 9
- 230000004438 eyesight Effects 0.000 description 9
- 235000013355 food flavoring agent Nutrition 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 230000003064 anti-oxidating effect Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000036737 immune function Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 229910000323 aluminium silicate Inorganic materials 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 235000013402 health food Nutrition 0.000 description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 239000011572 manganese Substances 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 230000004224 protection Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 5
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 5
- 229930195725 Mannitol Natural products 0.000 description 5
- 208000001132 Osteoporosis Diseases 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000002607 hemopoietic effect Effects 0.000 description 5
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 5
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 229910052748 manganese Inorganic materials 0.000 description 5
- 239000000594 mannitol Substances 0.000 description 5
- 235000010355 mannitol Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 206010067997 Iodine deficiency Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000007952 growth promoter Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 235000006479 iodine deficiency Nutrition 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 206010006956 Calcium deficiency Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010062767 Hypophysitis Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 206010022971 Iron Deficiencies Diseases 0.000 description 3
- 208000036626 Mental retardation Diseases 0.000 description 3
- 102000010909 Monoamine Oxidase Human genes 0.000 description 3
- 108010062431 Monoamine oxidase Proteins 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010048259 Zinc deficiency Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229940087168 alpha tocopherol Drugs 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 206010000242 Abortion threatened Diseases 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 2
- 208000001140 Night Blindness Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 208000002141 Pellagra Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 2
- 206010036600 Premature labour Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 206010039984 Senile osteoporosis Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000005985 Threatened Abortion Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000170 anti-cariogenic effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000002605 anti-dotal effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002790 anti-mutagenic effect Effects 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000005961 cardioprotection Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 208000007287 cheilitis Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 210000004246 corpus luteum Anatomy 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 239000000745 gonadal hormone Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 210000000777 hematopoietic system Anatomy 0.000 description 2
- 208000007475 hemolytic anemia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 201000010193 neural tube defect Diseases 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 208000005368 osteomalacia Diseases 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 208000026440 premature labor Diseases 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 210000004994 reproductive system Anatomy 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 208000035581 susceptibility to neural tube defects Diseases 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000009978 visual deterioration Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
- PNNHLULHRSZWPG-UHFFFAOYSA-J 1,5-dihydroxypentan-3-yl phosphate;2,3-dihydroxypropyl phosphate;manganese(2+) Chemical compound [Mn+2].[Mn+2].OCC(O)COP([O-])([O-])=O.OCCC(CCO)OP([O-])([O-])=O PNNHLULHRSZWPG-UHFFFAOYSA-J 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OAVRWNUUOUXDFH-UHFFFAOYSA-H 2-hydroxypropane-1,2,3-tricarboxylate;manganese(2+) Chemical compound [Mn+2].[Mn+2].[Mn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O OAVRWNUUOUXDFH-UHFFFAOYSA-H 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 206010001367 Adrenal insufficiency Diseases 0.000 description 1
- 206010001557 Albinism Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000003670 Carboxypeptidase B Human genes 0.000 description 1
- 108090000087 Carboxypeptidase B Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 241000207892 Convolvulus Species 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000003468 Ehrlich Tumor Carcinoma Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241001362421 Epimedium brevicornu Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 208000007984 Female Infertility Diseases 0.000 description 1
- 239000004277 Ferrous carbonate Substances 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 208000001362 Fetal Growth Retardation Diseases 0.000 description 1
- 206010070531 Foetal growth restriction Diseases 0.000 description 1
- 206010060919 Foetal malformation Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010018985 Haemorrhage intracranial Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 206010020571 Hyperaldosteronism Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010048865 Hypoacusis Diseases 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010021928 Infertility female Diseases 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 241000735234 Ligustrum Species 0.000 description 1
- 206010024929 Low set ears Diseases 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 208000008167 Magnesium Deficiency Diseases 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- JJWSNOOGIUMOEE-UHFFFAOYSA-N Monomethylmercury Chemical compound [Hg]C JJWSNOOGIUMOEE-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 102100030856 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 101710138657 Neurotoxin Proteins 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 208000003435 Optic Neuritis Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 108010076181 Proinsulin Proteins 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 206010041415 Spastic paralysis Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- 201000000839 Vitamin K Deficiency Bleeding Diseases 0.000 description 1
- 206010047634 Vitamin K deficiency Diseases 0.000 description 1
- 208000034700 Vitreous opacities Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 240000000038 Ziziphus mauritiana Species 0.000 description 1
- XSCQURIRMINZIY-UHFFFAOYSA-N [Se].COC(C1=CC=CC=C1)OC#N Chemical compound [Se].COC(C1=CC=CC=C1)OC#N XSCQURIRMINZIY-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000776 anti-sterility effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 239000011805 ball Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- MDXRFOWKIZPNTA-UHFFFAOYSA-L butanedioate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)CCC([O-])=O MDXRFOWKIZPNTA-UHFFFAOYSA-L 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940095672 calcium sulfate Drugs 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 230000010428 chromatin condensation Effects 0.000 description 1
- 229960000359 chromic chloride Drugs 0.000 description 1
- 229940046374 chromium picolinate Drugs 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 1
- HPCCGRCEBFBZQP-UHFFFAOYSA-N chromium;pyridine-3-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CN=C1 HPCCGRCEBFBZQP-UHFFFAOYSA-N 0.000 description 1
- 150000004777 chromones Chemical class 0.000 description 1
- 231100000244 chromosomal damage Toxicity 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- UBFWAFZODRGFIF-UHFFFAOYSA-N cyanic acid;selenium Chemical compound [Se].OC#N UBFWAFZODRGFIF-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- FWBOFUGDKHMVPI-UHFFFAOYSA-K dicopper;2-oxidopropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O FWBOFUGDKHMVPI-UHFFFAOYSA-K 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- MHJAJDCZWVHCPF-UHFFFAOYSA-L dimagnesium phosphate Chemical compound [Mg+2].OP([O-])([O-])=O MHJAJDCZWVHCPF-UHFFFAOYSA-L 0.000 description 1
- 229910000395 dimagnesium phosphate Inorganic materials 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000021038 drupes Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 235000019268 ferrous carbonate Nutrition 0.000 description 1
- RAQDACVRFCEPDA-UHFFFAOYSA-L ferrous carbonate Chemical compound [Fe+2].[O-]C([O-])=O RAQDACVRFCEPDA-UHFFFAOYSA-L 0.000 description 1
- 229960004652 ferrous carbonate Drugs 0.000 description 1
- 235000019850 ferrous citrate Nutrition 0.000 description 1
- 239000011640 ferrous citrate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 229960001604 ferrous succinate Drugs 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 208000030941 fetal growth restriction Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical class [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- BTIJJDXEELBZFS-UHFFFAOYSA-K hemin Chemical compound [Cl-].[Fe+3].[N-]1C(C=C2C(=C(C)C(C=C3C(=C(C)C(=C4)[N-]3)C=C)=N2)C=C)=C(C)C(CCC(O)=O)=C1C=C1C(CCC(O)=O)=C(C)C4=N1 BTIJJDXEELBZFS-UHFFFAOYSA-K 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008073 immune recognition Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000020082 intraepithelial neoplasia Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000015 iron(II) carbonate Inorganic materials 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100000863 loss of memory Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000000938 luteal effect Effects 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229960002337 magnesium chloride Drugs 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- 235000004764 magnesium deficiency Nutrition 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 235000001130 magnesium glycerophosphate Nutrition 0.000 description 1
- 239000011742 magnesium glycerophosphate Substances 0.000 description 1
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 description 1
- 235000015229 magnesium lactate Nutrition 0.000 description 1
- 239000000626 magnesium lactate Substances 0.000 description 1
- 229960004658 magnesium lactate Drugs 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- BHJKUVVFSKEBEX-UHFFFAOYSA-L magnesium;2,3-dihydroxypropyl phosphate Chemical compound [Mg+2].OCC(O)COP([O-])([O-])=O BHJKUVVFSKEBEX-UHFFFAOYSA-L 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 229940099607 manganese chloride Drugs 0.000 description 1
- 235000014872 manganese citrate Nutrition 0.000 description 1
- 239000011564 manganese citrate Substances 0.000 description 1
- 229940097206 manganese citrate Drugs 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- 235000018348 manganese glycerophosphate Nutrition 0.000 description 1
- 239000011584 manganese glycerophosphate Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000004141 microcephaly Diseases 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007472 neurodevelopment Effects 0.000 description 1
- 230000007658 neurological function Effects 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 1
- 235000011085 potassium lactate Nutrition 0.000 description 1
- 239000001521 potassium lactate Substances 0.000 description 1
- 229960001304 potassium lactate Drugs 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 229940093914 potassium sulfate Drugs 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XEABSBMNTNXEJM-UHFFFAOYSA-N propagermanium Chemical compound OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O XEABSBMNTNXEJM-UHFFFAOYSA-N 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940055619 selenocysteine Drugs 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 235000016491 selenocysteine Nutrition 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- FDNAPBUWERUEDA-UHFFFAOYSA-N silicon tetrachloride Chemical compound Cl[Si](Cl)(Cl)Cl FDNAPBUWERUEDA-UHFFFAOYSA-N 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 231100000462 teratogen Toxicity 0.000 description 1
- 239000003439 teratogenic agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 208000016794 vitamin K deficiency hemorrhagic disease Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 229940043825 zinc carbonate Drugs 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 229940110280 zinc methionine Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- CNMFGFBWPBBGKX-SCGRZTRASA-L zinc;(2s)-2-amino-4-methylsulfanylbutanoate Chemical compound [Zn+2].CSCC[C@H](N)C([O-])=O.CSCC[C@H](N)C([O-])=O CNMFGFBWPBBGKX-SCGRZTRASA-L 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a pharmaceutical composition for preventing birth defects and improving memory, which comprises Chinese date, wolfberry fruit, prepared fleece-flower root, epimedium, dodder, glossy privet fruit, radix rehmanniae preparata, rhizoma atractylodis macrocephalae, vitamin A, beta-carotin, vitamin complex B, vitamin C, vitamin D, vitamin E, vitamin K, macroelements (calcium, potassium and magnesium) and microelements (zinc, selenium, iron, chrome, copper, molybdenum, iodine, manganese, germanium, silicon and strontium). The pharmaceutical composition is mainly suitable for women before pregnancy, pregnant women and wet nurses, is very effective in preventing birth defects and improving memory, has the effects of health care and invigoration, and can not generate any side effect after long-term application.
Description
Technical field: the present invention relates to the Medicines and Health Product technical field; Also can improve the pharmaceutical composition of memory in particular for the prevention birth defect.
Background technology: birth defect refers to fetus in parent and in the rear organ formative process of birth, embryo and paedomorphosis disorder due to being interacted by the multiple environmental pathogenic factor in parent inside and outside and inherited genetic factors, comprise that morphosis is abnormal, 4 types of physiological metabolism obstacle, congenital mental retardation and intrauterine growth retardations etc.; Various countries' Prevalence rate of birth defect is up to 5% left and right of birth sum, great on the population quality impact, causes white elephant to family, society, has become the common great public health problem of paying close attention in the current whole world.
The pathogenic factors of birth defect is very complicated, and inherited genetic factors is arranged, and environmental factors also has other multiple uncertain factor.Environmental factors comprises biological factor, physical factor, chemical factor; The embryo is subject to the injury of environment harmful factor and other multiple uncertain factor, the birth defect sickness rate is increased, and eliminate these harmful factors, will make the birth defect sickness rate lower.
Pharmaceutical composition of the present invention is the policy of following prenatal and postnatal care, by eliminating the birth defect factor that causes to the embryo, the generation of prevention birth defect, reach the purpose that lowers the birth defect sickness rate, user is improved the effect of memory, favourable mothers and sons two generations's health simultaneously; Said composition comprises Fructus Jujubae, Fructus Lycii, Radix Polygoni Multiflori Preparata, Herba Epimedii, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae, vitamin A, beta-carotene, compound vitamin B, vitamin C, vitamin D, vitamin E, vitamin K and macroelement calcium, potassium, magnesium and trace element zinc, selenium, ferrum, chromium, copper, molybdenum, iodine, manganese, germanium, silicon, strontium.
Fructus Jujubae be a kind of be the QI invigorating class natural Chinese medicine of food and medicine, invigorating the spleen and replenishing QI is arranged, nourishing blood to tranquillize the mind, relax the effect of the property of medicine; The clinical deficiency of QI in middle-JIAO card that is used for the treatment of, syndrome of deficiency of blood, the diseases such as hysteria syndrome, same in order to relax the property of medicine with high strong medicine; Modern pharmacological research confirms that Fructus Jujubae has: 1, central inhibitory action; 2, strengthen immunologic function; 3, antimutagenic effect; 4, anti-allergy action; 5, antitumor action; 6, hypotensive effect; 7, hepatoprotective effect; 8, muscle strength reinforcing effect etc.
Fructus Lycii be a kind of be the natural Chinese medicine of food and medicine, liver and kidney tonifying is arranged, nourishing YIN and supplementing blood, replenishing vital essence to improve eyesight, the effect of nourishing the lung to arrest cough, be flat tonic thing simply; Ancient Chinese medicine is classified Fructus Lycii as on Chinese medicine product, wherein " book on Chinese herbal medicine converge with speech " to evaluation especially high, think that it has the advantage of tens kinds of Chinese medicines concurrently, claims it: " gas can be filled, and blood can be mended, Yang Kesheng, the moon can be grown, fire can fall, rheumatism can be gone "; Be mainly used in Liver and kidney two void, the soreness of the waist and knees of asthenia of essence and blood, have a dizzy spell, early whitening of beard and hair, visual deterioration, the diseases such as sexual hypofunction; Modern pharmacological research confirms that Fructus Lycii has: 1, strengthen immunity and reconcile immune effect; 2, anti-cancer and inhibiting tumor effect; 3, remove harmful free radical in body, fat-reducing liver-protecting effect; 4, hypoglycemic activity; 5, resisting fatigue and high temperature resistance effect; 6, strengthen the animal heart, cerebral tissue catalase, the activity of lactic acid dehydrogenase, can make superoxide dismutase activity in old human blood raise, and LPO reduces, can make hematopoietic stem cell strengthen, there is the effect of defying age and stimulating animal growth promoter; 7, promote intelligence and improve the function of remembering; 8, protection reproductive system effect; 9, antimutagenic effect etc.; The Fructus Lycii nature and flavor are gentle, to promoting human physiological metabolism's function, have much useful value.
Radix Polygoni Multiflori Preparata is the class natural Chinese medicine of enriching blood through concocting, enriches blood, and the effect of benefit essence; On tcm clinical practice, for blood deficiency, have a sleepless night, visual deterioration, spasm of muscles and vessels, the early whitening of beard and hair of damage of essence blood deficiency senilism, dizziness and blurred vision, tinnitus is hard of hearing, the diseases such as weakness of the waist and knees; Modern study confirms: 1, Radix Polygoni Multiflori Preparata can reduce relevant enzyme---the monoamine oxidase, MAO (Type B) that causes brain aging in the different partitioned organizations of brain; 2, supplement composition---the lecithin that forms nervous tissue; 3, antioxidation, anti-aging effects; 4, protection thymus effect; 5, strengthen immunologic function; 6, promote hemopoietic function etc.
Herba Epimedii is a kind ofly can kidney invigorating and YANG supporting be arranged as the natural Chinese medicine of health food, the effect of Eradicates wind dehumidifying; Clinical sterile for sexual impotence, cold womb is infertile, anemofrigid-damp arthralgia, the hemiplegia unsuccessful disease of waiting; Modern pharmacological research confirms that Herba Epimedii has: 1, strengthen gonad function, Herba Epimedii can strengthen hypothalamus-hypophysis-gonad axis function, to dog sperm, secretion has facilitation, can increase the weight of mice prostate, seminal vesicle, levator ani, showing has androgen-like action, Herba Epimedii extracting solution mouth is raised female rats, can improve reactivity and the corpus luteum that hypophysis generates releasing hormone to corpus luteum and generate plain reactivity, obviously increases normal rat antepituitary, ovary, uterus weight; 2, promote protein and nucleic acid synthetic, it is synthetic that the Herba Epimedii extracting solution can affect " yang deficiency " model mice DNA, and promote the synthetic of protein, regulates cellular metabolism, obviously increase the weight of animals and anti-freezing the time, can also significantly improve " deficiency of YIN " model mice DNA synthetic ratio; 3, strengthen immunologic function, Herba Epimedii all has facilitation to specificity and non-specific immunity; 4, osteoporosis, promote the bone tissue growth effect; 5, defying age, resisting oxygen lack; 6, heart tonifying, resist myocardial ischemia, blood pressure lowering, arrhythmia, the effects such as anticoagulant; 7, blood fat reducing, hypoglycemic activity; 8, antitussive, eliminate the phlegm, antiasthmatic effect; 9, to the brain cell protective effect; 10, the effect such as antiinflammatory, antibiotic, antiviral.
Semen Cuscutae is a kind ofly can have the YANG invigorating tonifying YIN as the deficiency tonifying kind natural Chinese medicine of health food, controlling nocturnal emission with astringent drugs reducing urination, the effect of improving eyesight antidiarrheal.Be mainly used in soreness of waist and knee joint, impotence and seminal emission, enuresis frequent micturition, deficiency of the liver and kindey, poor vision, deficiency of spleen-YANG and kidneyYANG, have loose bowels in loose stool, frequent fetal movement, blood leaking in gestation etc.Doctor trained in Western medicine is examined as chronic nephritis, diabetes, aldosteronism, hypothyroidism, sexual neurasthenie, hypoadrenocorticism, the climacteric syndrome person that belongs to the insufficiency of kidney-YANG, hypertension, interior Ménière belong to deficiency of the liver and kindey person, central serous chorioretinopathy, optic neuritis, vitreous opacity belong to deficiency of the liver and kindey, the order eyeball loses and supports the person, chronic gastroenteritis, gastric and duodenal ulcers belong to deficiency of spleen-YANG and kidneyYANG person, threatened abortion, habitual abortion belong to deficiency of the liver and kindey person; Modern pharmacological research confirms that Semen Cuscutae has: the activity of 1, obviously protecting hepatic injury; 2, increase the short luteal function of hypothalamic-pituitary-ovarian, improve hypophysis reactive effect to LH to LRH and ovary; 3, strengthen cardiac contractile force, preserved material, to the anesthetized dog intravenous injection, can make its blood pressure drops; 4, Semen Cuscutae be a kind of take strengthen humoral immunization and phagocytic function is main immunostimulant; 5, there is the antisterility effect; 6, mutation; 7, the effect such as antioxidation, defying age, anticancer, improving eyesight.
Fructus Ligustri Lucidi is a kind ofly can have the liver and the kidney tonifying as the nourishing YIN class natural Chinese medicine of health food, the effect that crow must improving eyesight; Clinical in soreness of the waist and knees, early whitening of beard and hair, hectic fever due to YIN-deficiency consumptive fever, night sweat seminal emission, the diseases such as dizzy order is dark, forgetful tinnitus.Modern pharmacological research confirms that Fructus Ligustri Lucidi has: 1, strengthen immunologic function; 2, mutation, suppress the allergy effect, and chromosome damage is had to protective effect; 3, blood sugar lowering, effect for reducing blood fat; 4, defying age, antioxidation; 5, function of increasing leukocyte; 6, increase the effect of coronary flow; 7, protect the liver in addition, the effect such as anticancer, antiinflammatory, antibiotic, diuresis, cough-relieving, cathartic, heart tonifying.
Radix Rehmanniae Preparata is nourishing YIN and supplementing blood class natural Chinese medicine, the effect that has the YIN nourishing of enriching blood, beneficial essence to fill out marrow.On tcm clinical practice for curing mainly blood deficiency and yellow complexion, menoxenia, metrostaxis, deficiency of kidney yin, soreness of the waist and knees, night sweat seminal emission, essence and blood two loses, have a dizzy spell, the diseases such as early whitening of beard and hair.Modern study confirms: 1, Radix Rehmanniae Preparata has the effect that promotes medulla hematopoietic system, also has the effect of hemostasis; 2, there is blood pressure lowering and protect myocardium effect; 3, obviously promote lymphocytic breeder reaction, significant reticuloendothelial system promotes active; The effects such as 4, blood lipid-reducing blood sugar-decreasing, antitumor, antioxidation, anoxia enduring, promotion liver glycogen be synthetic.
The Rhizoma Atractylodis Macrocephalae is a kind ofly can invigorating the spleen and benefiting QI be arranged as the QI invigorating class natural Chinese medicine of health food, the dampness diuretic, the hidroschesis consolidating superficial resistance, and in antiabortive effect; Ancient Chinese medicine is classified the Rhizoma Atractylodis Macrocephalae as on Chinese medicine product, antiabortive monarch drug, the panacea of fetus nourishing; Modern clinic is multiplex in cirrhotic ascites, diarrhoea, Mo Niai syndrome, edema spontaneous perspiration, frequent fetal movement etc.; Modern pharmacological research confirms: 1, Rhizoma Atractylodis Macrocephalae Wheat Protein, can alleviate lipid peroxidation, reduce the content of peroxide, avoid the destruction of harmful substance to cellularity and function, and be improved the active trend of SOD, the ability of enhancing body to free radical scavenging, thereby the damage of minimizing radical pair body; 2, the Rhizoma Atractylodis Macrocephalae has delaying senility function, Rhizoma Atractylodis Macrocephalae decoct can improve the erythrocytic superoxide dismutase of aged mouse (SOD) activity, suppresses the brain activity of monoamine oxidase simultaneously, can also suppress erythrocytic autoxidation haemolysis, directly remove free radical, show anti-aging effects; 3, the Rhizoma Atractylodis Macrocephalae has the enhancing immunization, and oral lymhocyte transformation rate and the serum IgG content of making of Rhizoma Atractylodis Macrocephalae decoct significantly rises, and shows that the Rhizoma Atractylodis Macrocephalae has immunostimulation, and can strengthen the vigor of macrophage, strengthens the phagocytic function of reticuloendothelial system; 4, anticancer tumor effect, Rhizoma Atractylodis Macrocephalae volatile oil has inhibitory action to murine sarcoma S180, and external have direct killing action to the ehrlich ascites tumor cell, and in vitro the Eca109 esophageal cancer cell is presented to inhibition, can make cell detachment, karyopycnosis, Chromatin condensation, cell does not divide or seldom division; 5, the Rhizoma Atractylodis Macrocephalae also has the blood lipid-reducing blood sugar-decreasing effect, antibacterial action, and blood coagulation resisting function, promote the brood body weight to increase, physical potentiation can make leukocyte count raise to the leukopenia by causing after chemotherapy or radiotherapy tumor; The compatibility Rhizoma Atractylodis Macrocephalae is to promote the absorption of medicament effective component in prescription for traditional Chinese medical science custom, and particularly compatibility gold, stone class medicine are to promote absorption and the utilization of mineral.
Vitamin A also claims retinol, is improved vision, prevents the effect of nyctalopia, and the anemia of pregnant woman of enhancing Abwehrkraft des Koepers function is arranged, and can promote mucopolysaccharide synthetic, affects renewal, the growth of osseous tissue, and long bone is grown to both-end; If vitamin A deficiency is prone to premature labor or fetal congenital deformity.Beta-carotene can change vitamin A under the effect of enzyme in vivo, the effect of performance vitamin A.
Vitamin B group participates in body internal protein, fat and sugar metabolism, makes the excitement of brain cell and suppresses in poised state, and it comprises vitamin B
1, vitamin B
2, nicotiamide, pantothenic acid, biotin, vitamin B
6, vitamin B
12, folic acid etc., collaborative performance physiological action in vivo.Vitamin B
1there is the effect that maintains the nervous system normal function, occur the phenomenons such as carbohydrate metabolism is incomplete, and heat energy is under-supply during shortage, thereby cause hypomnesis, affect the normal function of brain, if vitamin B
1abundance, can effectively form the energy of brain cell activity necessity, can improve memory, concentration power and learning capacity, vitamin B in addition
1suppress in addition cholinesterase, improve the function of cholinergic nerve; Vitamin B
2having another name called riboflavin, is the ingredient of many important coenzyme in body, and it participates in the substance metabolism in body, to the activity that sustains life, promotes fetus and baby's growth promoter to play an important role, vitamin B
2to maintain skin and the requisite vitamin of eye health, anemia of pregnant woman's vitamin B
2lack or can not cause or inspire pregnant early pregnancy vomiting completely, second trimester angular cheilitis, glossitis, cheilitis and premature infant's incidence rate increase; Nicotiamide claims again niacin amide or vitamin PP, and its physiological function is to participate in the body intracellular metabolic, maintains normal neurological function, and synthesizing of assurance gonadal hormone etc., pellagra can occur during shortage, and main manifestations is dermatitis, diarrhoea, dull-witted three large symptoms; Pantothenic acid extensively exists in each organism, participates in metabolic activity widely, and known have 70 plurality of enzymes in catalysis body different kind organism chemical reaction, all to need pantothenic acid to participate in, otherwise just can Metabolic disorder; Biotin is also a kind of vitamin B group, with other vitamin B group, coordinates to participate in the metabolism of human body matter and energy, and it is synthetic with nucleic acid, and the compositive relation of gonadal hormone is close, and it also has control poliosis, bareheaded effect; Vitamin B
6most important to the maincenter neurodevelopment, if shortage can make the nervus centralis hypoevolutism, intelligence descends, and it has the assistance vitamin B
1effect, be the vitamin that can improve concentration power and stimulate desire learn; Vitamin B
12participate in nucleic acid in vivo, choline, amino acid whose synthetic and fatty and sugared metabolism, to hemopoietic function of bone marrow, the gastrointestinal epithelial cells function, liver function and nervous system myelin function complete has certain effect, it is the necessary vitamin of intelligence of bringing into normal play, not only cause dysnoesia if lack, also there will be nutritional anemia, impact is to blood supply in brain; Folic acid participates in the synthetic of aminoacid and nucleic acid, and and vitamin B
12the common generation that promotes cell is with ripe, and during shortage, normal cell can not carry out mitosis, there will be the neurological symptom, as: the loss of memory, depression and dementia etc.; Human body can be at vitamin B in addition
12under the effect of folic acid as cofactors, by the serine of taking in and the synthetic choline of methionine, choline is the key component of acetylcholine, and acetylcholine is important neurotransmitter in human body; Folic acid, vitamin B are arranged again
6and vitamin B
12can work in coordination with the homotype cysteine of removing in human body, the homotype cysteine is a kind of neurotoxin, can cause the self murder of brain; There are some researches show, homocysteine is a kind of potential teratogen of independently growing, and with congenital heart disease and neural tube defects, is related closely; Homocysteine also can cause miscarriage, premature labor in addition, the clinical disastrous effect such as preeclampsia.
Vitamin C claims again ascorbic acid, vitamin C and collagen in close relations, the vessel softening effect is not only arranged, the effect purified the blood in addition, prevent arteriosclerosis, can also promote the absorption of human body to ferrum in food, for hemopoietic provides essential raw material, simultaneously, vitamin C regaining one's strength, the aspect effect such as allaying tiredness, keeping tensions down emotion is obvious; Pregnancy duration, anemia of pregnant woman's hypovitaminosis C or deficiency there will be subcutaneous hemorrhage, swelling and aching of gum, the symptom such as bleed, fester, the long-term lacking vitamin C easily has virus flu, and increases the danger of fetus teratogenesis, and famine can cause miscarriage.
Vitamin D is the sterols derivant, and the subcutaneous dehydrocholesterol of human body produces vitamin D through ultraviolet radiation
3, ergosterol produces vitamin D after ultraviolet radiation
2, the two originates different, and function is consistent, and in human nutrition, the importance of vitamin D is to regulate the metabolism of calcium and phosphorus; Vitamin D promotes calcium at intestinal absorption, be deficient in vitamin D a large amount of calcium by feces, discharged, thereby cause the human body calcium deficiency, rickets can occur in the child, become the calcium phosphorus of storing in human body to exhaust and can cause osteomalacia, modal osteomalacia crowd is anemia of pregnant woman, wet nurse and old people.
Vitamin E is all general designations with the bioactive chromone derivative of alpha-tocopherol, and wherein the activity of alpha-tocopherol is the highest.There is the effect of eliminating free radical, slow down aging, prevention maxicell hemolytic anemia, medically often adopting vitamin E treatment male and female infertility and threatened abortion; Vitamin E deficiency or can not make anemia of pregnant woman's reproductive system suffer damage completely, irreversible variation occurs in germinal epithelium, in addition, the phenomenons such as maxicell hemolytic anemia and shortening red blood cell life span also can occur.
The main Physiological Function of vitamin K is: 1, regulate the synthetic of clottable protein warmed, with synthesizing of thrombinogen and other thrombin in the assurance liver, guarantee the operation of clotting mechanism, intracranial hemorrhage often appears in neonate at birth, and its pathogenesis is relevant with pregnancy period parent vitamin K Deficiency of Intake; 2, guarantee the health of osseous tissue, the synthetic participation that depends on vitamin K of three kinds of protein in osteoblast.
Calcium is the macroelement that body weight for humans is wanted, main two aspects that play a part, the one, form the sclerous tissueses such as bone tooth, the 2nd, form the material that specific function is arranged with protein bound or with the form of calcium ion, form calcium in so-called miscible calcium pool and bone tooth and maintain dynamic equilibrium, in body, all cells all need its normal function of calcium competence exertion; Anemia of pregnant woman and wet nurse's calcium deficiency can affect the growth of its body constitution and fetus or infant, and calcium deficiency also can cause that endocrine dysfunction and cell cycle regulation are malfunctioning, and anemia of pregnant woman and wet nurse be due to physiological characteristics, the Deficiency of Intake of ubiquity calcium.
Potassium participates in the metabolic activity of cell, for the normal activity of some enzyme provides suitable condition, its outstanding effect is to maintain the normal irritability of myocardial cell, self-disciplining and conductivity, is regulating acid-base balance, maintains osmotic pressure and keeps the water balance aspect to play an important role; Hypokalemia and hyperkalemia all can produce serious infringement to human body, and the lighter can cause tired, irritated, and severe one can cause arrhythmia, even dead.
Magnesium topmost function in human body is the generation of containment free radical, and free radical is short old and feeble factor, is also the factor that mainly causes birth defect; Another function of magnesium is to bring into play the effect of protection skeleton together with vitamin D with calcium, and osteoporosis easily occurs magnesium deficiency, easily fractures; Magnesium also has cardioprotection and prevents and treats the function etc. of diabetes in addition.
Trace element zinc is merged in the biomacromolecule ligand---in protein, nucleic acid, film (being mainly memebrane protein), generate stable metallic biomacromolecule complex---metalloprotein, metalloproteinase nucleic acid complex etc., at present, known these materials participate in the synthetic and degradation process of carbohydrate, lipid, protein and nucleic acid, and the existence of zinc enzyme is arranged in six large fermentoids; Zinc is also the essential element that strengthens immune vigor; Zinc can promote that proinsulin is converted into insulin by activating protaminase, and zinc deficiency makes insulin be obstructed in the activity of peripheral tissues, causes glucose tolerance curve abnormal; Anemia of pregnant woman's zinc deficiency, can affect the growth promoter of fetus to some extent, so that cause all deformities of fetus; Zinc deficiency can cause brain development bad, incomplete development of mind.
Trace element-selenium has obvious reduction serum total cholesterol, triglyceride and lipid peroxide, improves high density lipoprotein, the effect of superabundant fats metabolism in acceleration bodies; Selenium also has the strong anti-oxidation function, and the protection embryo is not subject to the injury of superoxides, prevention of cardiac; Anticancer by strengthening immune recognition system to remove cancerous cell; Remove and the excretion heavy metal ion, hydrargyrum, methyl mercury, cadmium, lead etc. are had to Detoxication, and heavy metal pollution is mainly to cause the birth defect factor; Scarce selenium can make the human insulin secretion reduce, impaired glucose tolerance, and oxidation resistance descends and accelerates human senility and intelligence decline.
The main Physiological Function of trace elements iron is as hemoglobin, Myoglobin, and the ingredient of cytochrome etc. participates in transporting and the Tissue respiration process of the interior oxygen of body; Play central role in the conveying of oxygen and electronics; Contain ferrum in catalatic structure, and hydrogen peroxide relies on catalatic degraded, hydrogen peroxide is free radical the most dangerous in human body; Iron deficiency is common in infant, anemia of pregnant woman and wet nurse, causes iron deficiency anemia, and its cardinal symptom is to have a delicate constitution, and memory weakens, and ability to work descends, and iron deficiency also can exert an influence to other system of human body; As the nervous system iron deficiency, can affect the nerves conduction and make the child occur that intelligence reduces and behavior disorder.
Trace element chromium is a kind of essential trace element, only has the trivalent chromium can be for the supplement of chromium, and it can strengthen and promote the physiological action of insulin, and its can prevention of arterial sclerosis, strengthens immunologic function, enhancing development; Scarce chromium can cause growth promoter to be stagnated, and accelerates old and feeble.
Trace copper in human body mainly the form with the copper-containing metal enzyme play a role, participate in utilization, hemopoietic, phospholipid synthetic of ferrum, a series of metabolic processes such as collagenic connective tissue formation; The shortage of copper can cause collagen cross-linking obstacle in connective tissue, heart disease and anemia, leukopenia, and arterial wall elasticity weakens, albinism etc.
Trace element molybdenum is one of micro elements needed by human, it is the Constitution Elements of plurality of enzymes, participate in the utilization of ferrum, promote erythrocytic growth and maturation, can prevent anemia, and can help carbohydrate and fatty metabolism, it participates in removing the murder by poisoning of poisonous aldehydes in human body, eliminate human free radical, there is anticancer, defying age, enhancing immunity and anticariogenic function; Scarce molybdenum can bring out cardiovascular disease, cancer and dental caries.
Trace iodine is the main synthetic thyroid element that participates in human body, and thyroxinic physiological function is to regulate the organism metabolism level, affects the generation of body heat energy, blood glucose and ketoboidies level, muscle and nervous, many-sided functions such as body weight, intelligence and sexual function; Adult's iodine deficiency can cause thyromegaly, and fetus and neonate iodine deficiency can cause deaf and dumb, dull-witted, of short and small stature, spastic paralysis, mental retardation, microcephaly in various degree.The serious disease such as low set ears.
Trace element manganese participates in the formation of some enzymes in human body, and it is the metabolism of involved in sugar and lipid not only, and all works in protein, DNA and RVA are synthetic.
Trace element germanium has in human body regulates immune function, promotes growth, regulates the physiological equilibrium, removes free radical, defying age, the function such as anticancer.
It is synthetic that trace element silicon participates in mucopolysaccharide in human body, promotes bone growth, maintains epithelial tissue and connective tissue intensity and elasticity, safeguards normal function and the permeability of blood vessel, prevents sclerosis.
Trace element strontium is the normal ingredient of skeleton and tooth, prophylaxis of hypertension, heart disease; Relevant with nerve and muscle excitement, the stabilate cell membrane, promote union of fracture, prevents senile osteoporosis.
Application contains Fructus Jujubae, Fructus Lycii, Radix Polygoni Multiflori Preparata, Herba Epimedii, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae, vitamin A, beta-carotene, vitamin B
1, vitamin B
2, vitamin B
6, nicotiamide, pantothenic acid, biotin, vitamin B
12, folic acid, vitamin C, vitamin D, vitamin E, vitamin K and macroelement calcium, potassium, magnesium and trace element zinc, selenium, ferrum, chromium, copper, molybdenum, iodine, manganese, germanium, silicon, strontium be known as the compositions of active component, but by Fructus Jujubae, Fructus Lycii, Radix Polygoni Multiflori Preparata, Herba Epimedii, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae, vitamin A, beta-carotene, vitamin B
1, vitamin B
2, nicotiamide, pantothenic acid, biotin, vitamin B
6, vitamin B
12, folic acid, vitamin C, vitamin D, vitamin E, vitamin K
1with macroelement calcium, potassium, magnesium and trace element zinc, selenium, ferrum, chromium, copper, molybdenum, iodine, manganese, germanium, silicon, strontium compatibility, for the pharmaceutical composition that prevents birth defect also can improve memory, not yet report.
Current have multiplely for the medicine that improves memory or health food kind, but medicine or the health food for the improving memory that aim at pregnant front women, anemia of pregnant woman, wet nurse's development there is not yet; There is not yet for preventing the medicine label of birth defect rarely seen report that folic acid supplementation for neural tube defects is arranged; But its target spot is few, the link shortcoming, need perfect.And will prevent birth defect and can improve the effect of memory and there is not yet for same medicine person.
Summary of the invention: in order to overcome existing prevention birth defect and/or to improve the shortcoming and defect of remembering medicine, the purpose of this invention is to provide a kind of compositions, said composition is with Fructus Jujubae, vitamin B
6, vitamin B
12, folic acid is host, with Fructus Lycii, Radix Polygoni Multiflori Preparata, Herba Epimedii, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae, vitamin A, beta-carotene, vitamin B
1, vitamin B
2, nicotiamide, pantothenic acid, biotin, vitamin C, vitamin D, vitamin E, vitamin K and macroelement calcium, potassium, magnesium and trace element zinc, selenium, ferrum, chromium, copper, molybdenum, iodine, manganese, germanium, silicon, strontium be adjuvant; The collaborative vitamin B that increases of this host Fructus Jujubae
6, vitamin B
12, folic acid improves the effect of memory and prevention birth defect, passes through vitamin B simultaneously
6, vitamin B
12, folic acid supplements and strengthen the effect that Fructus Jujubae has invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind, the mitigation property of medicine.Due to the result of broad research, the inventor has found Fructus Jujubae, vitamin B
6, vitamin B
12, folic acid is the basis of effect host for preventing birth defect and/or improving memory, is aided with or is aided with respectively Fructus Lycii, Radix Polygoni Multiflori Preparata, Herba Epimedii, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae, vitamin A, beta-carotene, vitamin B
1, vitamin B
2, nicotiamide, pantothenic acid, biotin, vitamin C, vitamin D, vitamin E, vitamin K and macroelement calcium, potassium, magnesium and trace element zinc, selenium, ferrum, chromium, copper, molybdenum, iodine, manganese, germanium, silicon, strontium play the effect of addition complementation to prevention birth defect and/or the effect of improving memory.And the effective ingredient of each component has the health care benefiting action to human body, as the Fructus Jujubae of this compositions dosage used has the effect of invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind, the mitigation property of medicine; Fructus Lycii has liver and kidney tonifying, nourishing YIN and supplementing blood, replenishing vital essence to improve eyesight, the effect of nourishing the lung to arrest cough; Radix Polygoni Multiflori Preparata has enriching blood and replenishing vital essence, antioxidation, antidotal effect; Herba Epimedii has kidney invigorating and YANG supporting, and expelling wind and removing dampness promotes the effect that protein and nucleic acid is synthetic, and osteoporosis promotes the bone tissue growth effect; Semen Cuscutae has the YANG invigorating tonifying YIN, controlling nocturnal emission with astringent drugs reducing urination, the effect of improving eyesight antidiarrheal; Fructus Ligustri Lucidi has the effect of the liver and the kidney tonifying, the improving eyesight of crow palpus; The effects such as Radix Rehmanniae Preparata has the effect that promotes medulla hematopoietic system, and blood lipid-reducing blood sugar-decreasing, antitumor, antioxidation, promotion liver glycogen are synthetic; The Rhizoma Atractylodis Macrocephalae has that fetus nourishing is antiabortive, the effect of defying age, enhancing immunity and physical strength reinforcing; Trace element zinc is the necessary material of zinc enzyme in the interior six large fermentoids of human body, is also the essential element that strengthens immune vigor; But in the trace element-selenium acceleration bodies, the metabolism of superabundant fats, have the strong anti-oxidation function, prevention of cardiac function, anti-cancer function etc.; Trace elements iron participates in transporting and the Tissue respiration process of the interior oxygen of body, is the only element that prevents iron deficiency anemia; Trace element chromium has the prevention of arterial sclerosis, strengthens immunity, antidotal function; Trace copper participates in utilization, hemopoietic, phospholipid synthetic of ferrum; Trace element molybdenum has anticancer, defying age, enhancing immunity and anticariogenic function; Trace iodine can be prevented and treated the goiter that iodine deficiency causes, can prevent fetus and neonate iodine deficiency to cause the serious maldevelopment such as cretinism, mental retardation; Trace element manganese participates in the synthetic of protein, DNA and RNA; Trace element germanium has in human body regulates immune function, promotes growth, regulates the physiological equilibrium, removes free radical, defying age, the function such as anticancer; It is synthetic that trace element silicon participates in mucopolysaccharide in human body, promotes bone growth, maintains epithelial tissue and connective tissue intensity and elasticity, safeguards normal function and the permeability of blood vessel, prevents sclerosis; Trace element strontium is the normal ingredient of skeleton and tooth, prophylaxis of hypertension, heart disease; Relevant with nerve and muscle excitement, the stabilate cell membrane, promote union of fracture, prevents senile osteoporosis etc.; And for example vitamin A is improved vision, prevents the effect of nyctalopia etc.; Vitamin B
1can prevent and treat vitamin B1 deficiency, maintain the normal activity of nerve, digestion, muscle, blood circulation; Vitamin B
2to maintain skin and the requisite vitamin of eye health; Pellagra can occur in nicotinamide deficiency; The pantothenic acid shortage can cause Metabolic disorder; Biotin can be prevented and treated poliosis, alopecia; Vitamin B
6can eliminate intraepithelial neoplasia cells, strengthen immunologic function, the protection blood vessel; Vitamin B
12for various megaloblastic anemias, and neural disease; Folic acid also has cardioprotection and antitumaous effect; Vitamin C has vessel softening, purifies the blood, and prevents arteriosclerotic effect; Vitamin E has the effect of removing free radical, slow down aging; Vitamin K is regulated the synthetic of clottable protein warmed; Macroelement potassium maintains the normal irritability of myocardial cell, self-disciplining and conductivity; Macroelement calcium, magnesium and vitamin D are brought into play the effect of protection skeleton jointly; There is not incompatibility in this compositions, have no side effect, and cost is low, thereby forms the present invention.
The invention provides for preventing birth defect and can improving the pharmaceutical composition of remembering, it comprises with Fructus Jujubae, vitamin B
6, vitamin B
12, folic acid is host, with Fructus Lycii, Radix Polygoni Multiflori Preparata, Herba Epimedii, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae, vitamin A, beta-carotene, vitamin B
1, vitamin B
2, nicotiamide, pantothenic acid, biotin, vitamin C, vitamin D, vitamin E, vitamin K and macroelement calcium, potassium, magnesium and trace element zinc, selenium, ferrum, chromium, copper, molybdenum, iodine, manganese, germanium, silicon, the strontium active princlple that is adjuvant.
The mature fruit that Fructus Jujubae is Rhamnaceae machaka or dungarunga Fructus Jujubae (Ziziphus jujuba) Mill.var.inermis (Bge) Rehd; All there is cultivation all parts of the country, the ground such as main product Henan, Hebei, Shandong, Shanxi, Shaanxi, and the color of take is red, meat is thick, full, core is little, the sweet person that distinguishes the flavor of is as good; The present invention's Fructus Jujubae used can be with its extract as raw material.
The berry that Fructus Lycii is Solanaceae machaka or dungarunga Fructus Lycii Lycium chinense Mill for; Ovalize spindle shape, dry finished product slightly is crushed, long 1.5-2cm, diameter 4-8mm, orange red to kermesinus, distinguish the flavor of slightly sweet; Kind is more, and large with lycium barbarum Lycium darbarum L. fruit, matter is good famous; Be distributed in east Asia and Europe, all have all over China wild, more with the ground such as Ningxia, Gansu, Qinghai, the Inner Mongol, Shaanxi cultivations; The present invention's Fructus Lycii used can be with its extract as raw material.
The tuber that Radix Polygoni Multiflori is the perennial voluble herb Plant-Polygonum of Polygonaceae (Polygonum multiflorum Thunb).Main product in Henan, the ground such as Hubei, Guangxi.Two season of autumn and winter excavates when leaf is withered, cuts the sheet drying, claims Radix Polygoni Multiflori; Mix thoroughly with decoction of black soybean, inside and outside steaming extremely, be sepia, dry, claim Radix Polygoni Multiflori Preparata, the Radix Polygoni Multiflori Preparata temperature compensation is not dry, long-term taking safety; China's Ministry of Public Health is listed Radix Polygoni Multiflori Preparata in " article that can be used for health food " list; Radix Polygoni Multiflori Preparata of the present invention can be with its extract as raw material.
The aerial parts that Herba Epimedii is Berberidaceae herbaceos perennial Herba Epimedii (Epimedium brevicornum) and other sibling species for, main product in Shaanxi, the ground such as Shanxi, Sichuan, Hubei, Guangxi, be wild, the present invention's Herba Epimedii used can be with its extract as raw material.
The mature seed that Semen Cuscutae is convolvulus cuscuta plant Cuscuta chinensis Lam..Whole nation most area all has distribution.Extract aerial parts during fruit maturation autumn, dries, and lays seed.Give birth to use, or boil to mash and be used as cake.Be divided into two kinds of semen cuscutae japonicae and Semen Cuscutae.Semen Cuscutae is the main flow commodity.Semen cuscutae japonicae take that grain is full, pitchy evenly, the free from admixture person is as good; Semen Cuscutae take that grain is full, matter is solid, taupe brown or yellowish-brown be as good.The present invention's Semen Cuscutae used can be with its extract as raw material.
The ripe dry fruit that Fructus Ligustri Lucidi is Oleaceae evergreen shrubs plant Fructus Ligustri Lucidi (Ligustrum lu-cidus), be Berry-like drupe, and Long Circle, be about 1cm, and diameter 3~4mm is black-and-blue, slightly curved.After pluck cleaning, dry or steam after dry.Mainly originate in the ground such as Zhejiang, Jiangsu, Hunan.The present invention's Fructus Ligustri Lucidi used can be with its extract as raw material.
The tuber that Radix Rehmanniae Preparata is scrophulariaceae rehmannia glutinosa plant (Rehmannia glutinosa Libosch), concoct and form through processing.By take wine, Fructus Amomi, Pericarpium Citri Reticulatae as adjuvant through repeatedly steaming and shine, extremely inside and outside darkish complexion is glossy, and quality is soft glutinous greasy; Section use, or parch to black is used.Take surperficial corvinus, glossy, stickiness is large, soft glossy, the sweet person that distinguishes the flavor of of matter is as good; Especially with Henan product bosom celebrating Radix Rehmanniae the best, be one of four-Huai medicine; The processed with wine Radix Rehmanniae Preparata is mended and oiliness, is one of the most frequently used Chinese medicine; Radix Rehmanniae Preparata of the present invention can be with its extract as raw material.
The rhizome that the Rhizoma Atractylodis Macrocephalae is the Compositae herbaceos perennial Rhizoma Atractylodis Macrocephalae (Atractylodes macrocephala koidz).Main product in Zhejiang, the ground such as Hubei, Hunan.Gather winter, dries or dry, and life use or parching with earth, parched with bran are used.The present invention's Rhizoma Atractylodis Macrocephalae used can be with its extract as raw material.
For vitamin B of the present invention
1(VitaminB
1), vitamin B
2(VitaminB
2), nicotiamide (Nicotinamide), pantothenic acid (Pantothenic Acid), biotin (Vitamin H), vitamin B
6(VitaminB
6), vitamin B
12(VitaminB
12), folic acid (Folic Acid), vitamin C (Vitamin C), all are water soluble vitamins, do not accumulate in vivo, vitamin A (Vitamin A), vitamin D (VitaminD), vitamin E (Vitamin E), vitamin K (Vitamin K), be fatsoluble vitamin, beta-carotene (Beta Carotene) is the precursor substance of vitamin A, useful and harmless by the present invention's dosage used, zinc (Zn), selenium (Se), ferrum (Fe), chromium (Cr), copper (Cu), molybdenum (Mo), iodine (I), manganese (Mn) are micro elements needed by human, germanium (Ge), silicon (Si), strontium (Sr) are human body possibility essential trace element, and calcium (Ca), potassium (K), magnesium (Mg) are the macroelements of needed by human, macroelement calcium in the present invention can be selected calcium gluconate, calcium acetate, calcium caseinate, calcium chloride, calcium citrate, calcium malate, calcium cirate malate, calcium hydrogen phosphate, dalcium biphosphate, calcium phosphate, calcium sulfate, calcium ascorbate, calcium glycerophosphate, calcium lactate, calcium carbonate etc., macroelement potassium can be selected potassium carbonate, potassium chloride, potassium citrate, dipotassium hydrogen phosphate, potassium gluconate, potassium sulfate, potassium glycerinophosphate, potassium lactate etc., macroelement magnesium can be selected magnesium chloride, magnesium gluconate, magnesium lactate, magnesium citrate, magnesium hydrogen phosphate, magnesium phosphate, magnesium glycerophosphate, magnesium carbonate etc., trace element zinc can be selected zinc citrate, zinc gluconate, zinc acetate, zinc carbonate, zinc oxide, zinc chloride, zinc lactate, zinc sulfate, single zinc methionine etc., trace element-selenium can be selected Selenomethionine, methoxybenzyl cyanic acid selenium, the two cyanic acid selenium of phenylene, sodium selenite, selenocarrageenan, selenocysteine, the selenizing methionine, sodium selenate etc., trace elements iron can be selected Ferrous gluconate, ferrous lactate, ferric ammonium citrate, iron chloride, ferric citrate, ferrous carbonate, ferrous citrate, ferrous fumarate, heme iron, ferric phrophosphate, protohemin, ferrous succinate, ferrous sulfate etc., trace element chromium can be selected chromium trichloride, nicotinic acid chromium, chromium picolinate, chromium yeast etc., trace copper can be selected curpic carbonate, copper citrate, copper gluconate, copper sulfate etc., trace element molybdenum can be selected ammonium molybdate, sodium molybdate etc., trace iodine can be selected potassium iodate etc., and trace element manganese can be selected manganese sulfate, manganese gluconate, manganese glycerophosphate, manganese chloride, manganese citrate, trace element silicon can be selected Silicon chloride., and trace element germanium can be selected Carboxyethyl-germanium Sesquioxide, germanium-enriched yeast, trace element strontium can be selected strontium chloride etc., and professional production factory and supplier are all arranged.
Compositions of the present invention mainly is applicable to women in pregnant early stage, anemia of pregnant woman and wet nurse, be subject to the impact of the factors such as geology, food chain, dietetic life custom and Time of Administration length, the effective dose that the crowd that benefits from benefits from this compositions each component has certain difference, by the present invention, the effective dose of Fructus Jujubae extract is counted 300-10000mg/ days with whole crude drug, the effective dose of Fructus Lycii extract is counted 300-10000mg/ days with whole crude drug, the effective dose of Radix Polygoni Multiflori Preparata extract is counted 200-8000mg/ days with whole crude drug, the effective dose of Herba Epimedii extract is counted 300-10000mg/ days with whole crude drug, the effective dose of Semen Cuscutae extract is counted 300-12000mg/ days with whole crude drug, the effective dose of Fructus Ligustri Lucidi extract is counted 300-10000mg/ days with whole crude drug, the effective dose of Radix Rehmanniae Preparata extract is counted 0-8000mg/ days with whole crude drug, the effective dose of Rhizoma Atractylodis Macrocephalae extract is counted 0-15000mg/ days with whole crude drug, vitamin B
1effective dose be 0.5-20mg/ days, vitamin B
2effective dose be 0.5-20mg/ days, the effective dose of nicotiamide is 5-50mg/ days, the effective dose of pantothenic acid is 2-20mg/ days, the effective dose of biotin is 0.01-0.1mg/ days, vitamin B
6effective dose be 0.5-10mg/ days, the effective dose of vitamin B12 is 0.001-0.025mg/ days, the effective dose of folic acid is 0.1-1mg/ days, ascorbic effective dose is 30-500mg/ days, and the effective dose of vitamin A and/or beta-carotene (take retinol equivalent) is 250-800 μ gRE/ days, the effective dose of vitamin D is 0.0015-0.01mg/ days, the effective dose of vitamin E (take alpha-tocopherol equivalent) is 5-150mg α-TE/ days, the effective dose of vitamin K is 0-0.12mg/ days, the effective dose of macroelement calcium is counted 100-1000mg/ days with element calcium, the effective dose of potassium is counted 0-1200mg/ days with Element Potassium, the effective dose of magnesium is counted 30-300mg/ days with element magnesium, the effective dose of trace element zinc is counted 5-20mg/ days with element zinc, the effective dose of selenium is counted 0.015-0.1mg/ days with elemental selenium, the effective dose of ferrum is counted 5-20mg/ days with elemental iron.The effective dose of chromium is counted 0.015-0.15mg/ days with elemental chromium, the effective dose of copper is counted 0.5-2mg/ days with elemental copper, the effective dose of molybdenum is counted 0.02-0.06mg/ days with molybdenum, the effective dose of iodine is counted 0-0.2mg/ days with elemental iodine, the effective dose of manganese is counted 1-3mg/ days with element manganese, the effective dose of germanium is counted 0-3.8mg/ days with elements germanium, and the effective dose of silicon is counted 0-50mg/ days with elemental silicon, and the effective dose of strontium is counted 0-2mg/ days with elements strontium.
Compositions of the present invention can or directly be taken by following pharmaceutical dosage forms dispenser, for example, oral formulations is (as granule, powder, capsule, ball, sheet, dry syrup, liquid formulation), or food is as food (as cookies), that the additive known with other mixes and prepare, this class additive is for example: carrier, disintegrating agent, slow releasing agent, excipient, filler, covering, binding agent, lubricant, antioxidant, coating agent, coloring agent, correctives, sweeting agent, sucrose succedaneum, nutrition enhancer, flavouring agent, surfactant, plasticizer, the PH regulator, freshener, suspending agent, defoamer, antiseptic, thickening agent, solubilisation aids etc., by usual way be prepared or using them as functional component or additive add food.
By the present invention, Fructus Jujubae, Fructus Lycii, Radix Polygoni Multiflori Preparata, Herba Epimedii, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae, vitamin A, beta-carotene, compound vitamin B, vitamin C, vitamin D, vitamin E, vitamin K and macroelement calcium, potassium, magnesium and trace element zinc, selenium, ferrum, chromium, copper, molybdenum, iodine, manganese, germanium, silicon, strontium each component can be distinguished preparation, use after the preparation of each component can being mixed while using or mix when different and use.
Advantage of the present invention is that this compositions eliminates from too many levels, multisystem, many target spots the many factors that causes birth defect and cause hypomnesis, the effect of collaborative performance effect is arranged between each component, also can improve memory to the prevention birth defect significant effect is arranged, sufficient raw, cost is low, and in compositions, each component has no side effect, without incompatibility, also can improve memory except the prevention birth defect, human body is still had to the health care benefiting action.
Subordinate list 1: this compositions and Fructus Jujubae component and vitamin B
6, vitamin B
12, the young rat/mouse labyrinth test effect of folic acid component and vitamin added elements component relatively:
Subordinate list 2: this compositions and Fructus Jujubae component and vitamin B
6, vitamin B
12, folic acid component and vitamin added elements component Aged Mice maze test effect relatively:
Describe the present invention in detail below with reference to embodiment and test implementation example effect comparison list.
Embodiment 1:
By the starch of said components and appropriate amount, polyvinyl pyrrolidone, light anhydrous silicic acid, Polyethylene Glycol and flavoring agent evenly are mixed and made into independent 9, every day 3 times, each 3.
Embodiment 2:
Said components is further mixed as aluminosilicate magnesium, poly-solvate 60 and propylene glycol equably with the additive of appropriate amount, the gained mixture is inserted to capsule equably and 9 capsules, every day 3 times, each 3 capsules.
Embodiment 3:
Said components is further mixed as aluminosilicate magnesium, poly-solvate 60 and propylene glycol equably with the additive of appropriate amount, the gained mixture is inserted to capsule equably and 9 capsules, every day 3 times, each 3 capsules.
Embodiment 4:
By the starch of said components and appropriate amount, polyvinyl pyrrolidone, light anhydrous silicic acid, Polyethylene Glycol and flavoring agent evenly are mixed and made into independent 9, every day 3 times, each 3.
Embodiment 5:
Above-mentioned component and appropriate amount flavoring agent are received with after the high sweetener sucralose evenly mixes as citric acid, then sneaked in 100g flour, after adding appropriate culture propagation, then add an egg bake to become bread, as the staple food of a staggering amount.
Embodiment 6:
Above-mentioned component is further mixed as mannitol, hydroxypropyl cellulose, aluminosilicate magnesium and flavoring agent equably with the additive of appropriate amount, then the gained mixture is made to 3 bag shot-like particles.Take every day 3 times, each serving a bag.
Embodiment 7:
Above-mentioned component is further mixed as mannitol, hydroxypropyl cellulose, aluminosilicate magnesium and flavoring agent equably with the additive of appropriate amount, then the gained mixture is made to 3 bag shot-like particles.Take every day 3 times, each serving a bag.
Embodiment 8:
Above-mentioned component is further mixed as mannitol, hydroxypropyl cellulose, aluminosilicate magnesium and flavoring agent equably with the additive of appropriate amount, then the gained mixture is made to 3 bag shot-like particles.Take every day 3 times, each serving a bag.
Embodiment 9:
Above-mentioned component is further mixed as mannitol, hydroxypropyl cellulose, aluminosilicate magnesium and flavoring agent equably with the additive of appropriate amount, then the gained mixture is made to 3 bag shot-like particles.Take every day 3 times, each serving a bag, serve on 7, withdraw at 7 days at 2 taking medicine twice a day.
Embodiment 10:
Above-mentioned component is further mixed as mannitol, hydroxypropyl cellulose, aluminosilicate magnesium and flavoring agent equably with the additive of appropriate amount, then the gained mixture is made to 3 bag shot-like particles.Take every day 3 times, each serving a bag.
Belong to nontoxic level through animal experiment proved compositions; The crowd takes and also has no toxicity.
Subordinate list 1: this compositions and Fructus Jujubae component and vitamin B
6, vitamin B
12, the young rat/mouse labyrinth test effect of folic acid component and vitamin added elements component relatively:
Subordinate list 2: this compositions and Fructus Jujubae component and vitamin B
6, vitamin B
12, folic acid component and vitamin added elements component Aged Mice maze test effect relatively:
Annotate: in subordinate list 1, subordinate list 2, each group is tested by dosage feed in table respectively in 60 days; In table, the each component consumption converts by per kilogram of body weight respectively.
Select 120 of newly-married healthy womens, 28 years old mean age, 6 months from pregnant start to take continuously this compositions host, within 6 months, follow up a case by regular visits to none routine birth defect to baby dues.With the associated materials statistics, contrast, Fetal malformation account for the newborn population sum 4-6% there were significant differences.
From table 1, table 2, can obviously find out, this compositions by rat/mouse labyrinth test with compositions in Fructus Jujubae component and vitamin B
6, vitamin B
12, the contrast of folic acid component and vitamin added elements component, the statistical result of mistake percentage rate, the function of this composition for improved memory is better than Fructus Jujubae component or vitamin B
6, vitamin B
12, folic acid component and vitamin added elements component; With the blank group, significant difference is relatively arranged.
Claims (10)
3. according to claim 1ly for preventing birth defect and can improving the pharmaceutical composition of remembering, it is characterized in that, it is made by weight ratio by following raw materials according:
。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013104243830A CN103446269A (en) | 2013-09-17 | 2013-09-17 | Pharmaceutical composition for preventing birth defects and improving memory |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013104243830A CN103446269A (en) | 2013-09-17 | 2013-09-17 | Pharmaceutical composition for preventing birth defects and improving memory |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103446269A true CN103446269A (en) | 2013-12-18 |
Family
ID=49729382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013104243830A Pending CN103446269A (en) | 2013-09-17 | 2013-09-17 | Pharmaceutical composition for preventing birth defects and improving memory |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103446269A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016044056A1 (en) * | 2014-09-16 | 2016-03-24 | New Chapter, Inc. | Supplement for a breastfeeding woman |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101264140A (en) * | 2008-05-12 | 2008-09-17 | 北京冠五洲生物科学研究院 | Medicinal composition for preventing birth defect and improving memory and intelligence |
| CN101306056A (en) * | 2008-06-12 | 2008-11-19 | 北京冠五洲生物科学研究院 | Medicine composition for preventing the birth defect and improving the memory |
| CN101366840A (en) * | 2008-09-26 | 2009-02-18 | 北京冠五洲生物科学研究院 | Medicament composition for preventing birth defection and improving memory |
| CN101366780A (en) * | 2008-09-22 | 2009-02-18 | 北京冠五洲生物科学研究院 | Pharmaceutical combination for preventing birth defect and improving anamnesis |
| CN101366868A (en) * | 2008-09-22 | 2009-02-18 | 北京冠五洲生物科学研究院 | Medicament composition for preventing birth defect, improving memory and intelligence |
| CN101396419A (en) * | 2008-05-29 | 2009-04-01 | 北京冠五洲生物科学研究院 | Medicine composition for preventing the birth defect and improving the memory |
-
2013
- 2013-09-17 CN CN2013104243830A patent/CN103446269A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101264140A (en) * | 2008-05-12 | 2008-09-17 | 北京冠五洲生物科学研究院 | Medicinal composition for preventing birth defect and improving memory and intelligence |
| CN101396419A (en) * | 2008-05-29 | 2009-04-01 | 北京冠五洲生物科学研究院 | Medicine composition for preventing the birth defect and improving the memory |
| CN101306056A (en) * | 2008-06-12 | 2008-11-19 | 北京冠五洲生物科学研究院 | Medicine composition for preventing the birth defect and improving the memory |
| CN101366780A (en) * | 2008-09-22 | 2009-02-18 | 北京冠五洲生物科学研究院 | Pharmaceutical combination for preventing birth defect and improving anamnesis |
| CN101366868A (en) * | 2008-09-22 | 2009-02-18 | 北京冠五洲生物科学研究院 | Medicament composition for preventing birth defect, improving memory and intelligence |
| CN101366840A (en) * | 2008-09-26 | 2009-02-18 | 北京冠五洲生物科学研究院 | Medicament composition for preventing birth defection and improving memory |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016044056A1 (en) * | 2014-09-16 | 2016-03-24 | New Chapter, Inc. | Supplement for a breastfeeding woman |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101366871A (en) | Medicament composition for preventing birth defect and improving memory | |
| CN103446340A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN101791355A (en) | Medicine composition used for preventing birth defects, improving memory and regulating immunity | |
| CN103446251A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN101306056A (en) | Medicine composition for preventing the birth defect and improving the memory | |
| CN103446215A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103463155A (en) | Pharmaceutical composition used for preventing birth defects and improving memory | |
| CN103463167A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103479739A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN101269127A (en) | Pharmaceutical combination for preventing birth defect and improving anamnesis | |
| CN103446269A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103446223A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103463171A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103446252A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN104069257A (en) | Drug composition used for preventing birth defects and improving memory | |
| CN104069259A (en) | Medicinal composition for preventing birth defects and improving memory | |
| CN104069256A (en) | Drug composition used for preventing birth defects and improving memory | |
| CN101791354A (en) | Medicine composition used for interfering in and preventing birth defects and improving memory | |
| CN101269146A (en) | Pharmaceutical combination for preventing birth defect and improving anamnesis | |
| CN103446219A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103446225A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103446200A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103446430A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103446216A (en) | Pharmaceutical composition for preventing birth defects and improving memory | |
| CN103446436A (en) | Pharmaceutical composition for preventing birth defects and improving memory |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131218 |